We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Clinical Updates

Enhancing Pediatric Literacy Promotion for Latino Families: Efficacy of Text Messaging and Resource Referrals in a 3-Arm Randomized Controlled Trial

MedXY Editorial Team•Oct 2, 2026•Clinical Updates
pediatric literacyLatino familiescommunity referralstext messagingrandomized controlled trial

Highlights

  • Integration of text message reminders into primary care literacy promotion significantly improves child language development among Latino families.
  • Combining text messages with community resource referrals enhances social-emotional development and parental verbal responsiveness.
  • The trial confirms the feasibility and potential scalability of hybrid implementation strategies in underserved populations.
  • Interventions are particularly impactful in families with low educational attainment and limited English proficiency.

Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Enhanced Psychosocial Functioning in Schizophrenia: Clinical Trial Evidence for Modified Psychodynamic Psychotherapy in GermanyA German randomized controlled trial demonstrates that Modified Psychodynamic Psychotherapy for Schizophrenia (MPP-S) combined with standard care significantly improves psychosocial functioning over two to three years compared to standard cOct 14, 2026Evaluating Early Palliative Care Impact on End-of-Life Outcomes in Surgical Cancer Patients: Insights from the SOPE TrialA randomized trial found no significant benefit of early specialist palliative care on end-of-life outcomes among patients undergoing curative abdominal cancer surgery, suggesting tailored rather than routine involvement.Oct 11, 2026Comparing Side-to-Side and End-to-Side Gastrojejunostomy for Reducing Delayed Gastric Emptying After Pancreatoduodenectomy: Insights from the IPAD Randomized TrialA randomized trial found no significant difference in delayed gastric emptying rates between side-to-side and end-to-side gastrojejunostomy after pancreatoduodenectomy, with comparable postoperative outcomes and quality of life.Oct 10, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Cardiology
Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Evaluating Gastrojejunostomy Techniques in Pancreatoduodenectomy: Side-to-Side vs End-to-Side Approaches and Impact on Delayed Gastric EmptyingThe IPAD randomized trial shows no significant difference in delayed gastric emptying rates between side-to-side and end-to-side gastrojejunostomy after pancreatoduodenectomy, with comparable postoperative outcomes and quality of life.Oct 9, 2026
Immunogenicity up to Age 5 Following Single- or Two-Dose Infant Primary Series of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccine with Booster in South Africa: Extended RCT Follow-UpThis review synthesizes long-term immunogenicity data from a South African RCT comparing 1+1 and 2+1 infant PCV10 and PCV13 schedules. PCV13 1+1 schedules maintain durable immunity up to age 5, supporting schedule optimization in establisheOct 3, 2026
Serial Ketamine Infusions Show Promise in Treatment-Resistant Bipolar Depression: A Groundbreaking Randomized TrialA recent randomized clinical trial reveals that adjunctive intravenous ketamine significantly reduces depressive symptoms in treatment-resistant bipolar depression, with good safety and tolerability compared to midazolam.Sep 27, 2026